Immunovia AB (publ) (STO:IMMNOV)
0.1848
-0.0024 (-1.28%)
Jul 17, 2026, 5:30 PM CET
Immunovia AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 56.09 | 77.46 | 25.32 | 76.79 | 106.04 | 287.41 |
Cash & Short-Term Investments | 56.09 | 77.46 | 25.32 | 76.79 | 106.04 | 287.41 |
Cash Growth | 48.89% | 205.94% | -67.03% | -27.59% | -63.10% | -38.65% |
Accounts Receivable | 0.09 | 0.04 | 0 | 0.15 | 0.25 | 0.07 |
Other Receivables | - | 1.06 | 1.71 | - | - | - |
Total Trade Receivables | 0.09 | 1.1 | 1.71 | 0.15 | 0.25 | 0.07 |
Inventory | 0.17 | 0.12 | 0 | 0 | 2.02 | 2.15 |
Other Current Assets | 2.17 | 1.73 | 1.57 | 3.58 | 7.31 | 7.47 |
Total Current Assets | 58.52 | 80.41 | 28.59 | 80.51 | 115.62 | 297.1 |
Net Property, Plant & Equipment | 0.5 | 0.97 | 1.95 | 15.12 | 47.88 | 46.53 |
Other Intangible Assets | 6.55 | 6.72 | 1.94 | 2.55 | 133.6 | 147.15 |
Other Long-Term Assets | 0.13 | 0.13 | 0.55 | 0.51 | 3.5 | 3.03 |
Total Assets | 65.7 | 88.21 | 33.04 | 98.68 | 300.59 | 493.81 |
Accounts Payable | - | 5.64 | 0.88 | 2.5 | 1.58 | 3.07 |
Accrued Expenses | - | 2.66 | 7.84 | 15.01 | 15.17 | 20.21 |
Short-Term Debt | 0.48 | 0.86 | 0.68 | - | - | - |
Current Portion of Leases | - | - | - | 8.48 | 4.87 | 6.11 |
Other Current Liabilities | 18.72 | 14.31 | 12 | 3.92 | 2.46 | 3.37 |
Total Current Liabilities | 19.2 | 15.69 | 15.69 | 29.9 | 24.09 | 32.75 |
Long-Term Leases | - | 0 | 0 | 1.79 | 32.7 | 27.16 |
Other Long-Term Liabilities | - | 7.78 | 5.71 | 0 | - | - |
Total Long-Term Liabilities | - | 7.78 | 5.71 | 1.79 | 32.7 | 27.16 |
Total Liabilities | 19.2 | 23.48 | 21.39 | 31.69 | 56.79 | 59.91 |
Common Stock | 20.18 | 20.18 | 5.09 | 2.26 | 1.13 | 1.13 |
Additional Paid-in Capital | 1,309 | 1,309 | 1,186 | 1,136 | 1,016 | 1,016 |
Accumulated Other Comprehensive Income | 16.8 | 16.59 | -44.13 | -12.92 | -24.31 | -1.66 |
Retained Earnings | -1,299 | -1,281 | -1,135 | -1,059 | -749.39 | -581.3 |
Shareholders' Equity | 46.5 | 64.74 | 11.65 | 66.99 | 243.8 | 433.9 |
Total Liabilities & Equity | 65.7 | 88.21 | 33.04 | 98.68 | 300.59 | 493.81 |
Total Debt | 0.48 | 0.86 | 0.68 | 10.27 | 37.57 | 33.26 |
Net Cash (Debt) | 55.61 | 76.6 | 24.64 | 66.52 | 68.47 | 254.14 |
Net Cash Growth | -27.41% | 210.91% | -62.96% | -2.84% | -73.06% | -41.62% |
Net Cash Per Share | 0.18 | 0.22 | 0.30 | 1.71 | 3.02 | 11.23 |
Book Value | 46.5 | 64.74 | 11.65 | 66.99 | 243.8 | 433.9 |
Book Value Per Share | 0.15 | 0.19 | 0.14 | 1.72 | 10.77 | 19.17 |
Tangible Book Value | 39.95 | 58.02 | 9.71 | 64.44 | 110.21 | 286.76 |
Tangible Book Value Per Share | 0.13 | 0.17 | 0.12 | 1.66 | 4.87 | 12.67 |